Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 3075 of 3173 entries
View as:

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Phase: N/A Priority: Normal
NCT ID: NCT05355701 Org: User:
Start: 07/05/22 End: 09/28/28 Due: 09/28/29

To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05805826 Org: User:
Start: 03/23/23 End: 08/28/28 Due: 08/28/29

Real World Utilization and Outcomes With Dacomitinib First Line Treatment for EGFR Mutation-positive Advanced Non Small Cell Lung Cancer Among Asian Patients - A Multi Center Chart Review

Phase: N/A Priority: Normal
NCT ID: NCT04609319 Org: User:
Start: 06/11/21 End: 05/28/24 Due: 05/28/25

A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Phase: N/A Priority: Normal
NCT ID: NCT02222493 Org: User:
Start: 08/26/14 End: 06/01/17 Due: 06/01/18

A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00150267 Org: User:
Start: 02/28/02 End: - Due: -

Treatment With SU11248 in Patients With Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00056693 Org: User:
Start: 04/30/03 End: 09/30/06 Due: 09/30/07

A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06172348 Org: User:
Start: 02/01/24 End: 03/28/24 Due: 03/28/25

Tanezumab In Osteoarthritis Of The Knee (2)

Phase: N/A Priority: Normal
NCT ID: NCT00830063 Org: User:
Start: 05/05/09 End: 08/31/10 Due: 08/31/11

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT05487040 Org: User:
Start: 09/07/22 End: 07/11/23 Due: 07/11/24

Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02118766 Org: User:
Start: 03/31/14 End: 04/30/15 Due: 04/30/16

A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00615446 Org: User:
Start: 03/31/05 End: 05/31/09 Due: 05/31/10

Study Of The Mechanism Of Action Of CP-690,550 In The Skin Of Subjects With Moderate To Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01710046 Org: User:
Start: 03/31/13 End: 11/30/13 Due: 11/30/14

Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00744978 Org: User:
Start: 07/31/09 End: 11/30/10 Due: 11/30/11

Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis

Phase: N/A Priority: Normal
NCT ID: NCT00496197 Org: User:
Start: 07/31/07 End: 06/30/10 Due: 06/30/11

A Phase 1 Study To Estimate The Effects Of PD 0332334 On Lithium Pharmacokinetics In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00820794 Org: User:
Start: 05/31/09 End: 06/30/09 Due: 06/30/10

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

Phase: N/A Priority: Normal
NCT ID: NCT01323270 Org: User:
Start: 03/18/11 End: 02/19/13 Due: 02/19/14

A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 To 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT02052726 Org: User:
Start: 01/22/14 End: 05/05/15 Due: 05/05/16

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS

Phase: N/A Priority: Normal
NCT ID: NCT04258995 Org: User:
Start: 02/11/20 End: 09/15/20 Due: 09/15/21

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Phase: N/A Priority: Normal
NCT ID: NCT00428220 Org: User:
Start: 07/31/07 End: 09/30/14 Due: 09/30/15

A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02014272 Org: User:
Start: 09/30/12 End: 10/31/12 Due: 10/31/13

A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05597085 Org: User:
Start: 03/08/23 End: 07/10/23 Due: 07/10/24

Study Of SU011248 In Patients With Metastatic Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00092001 Org: User:
Start: 01/31/05 End: 03/31/07 Due: 03/31/08

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05968599 Org: User:
Start: 07/24/23 End: 02/14/25 Due: 02/14/26

A Study to Compare Zavegepant Concentration Using Samples Collected From the Vein Versus Patient-Centric Microsampling

Phase: N/A Priority: Normal
NCT ID: NCT05948085 Org: User:
Start: 07/10/23 End: 09/05/23 Due: 09/05/24

Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01086397 Org: User:
Start: 02/28/10 End: 10/31/11 Due: 10/31/12